Vicarious Surgical Inc.

RBOT OTC SEC CIK 1812173
Follow Vicarious Surgical Weekly email: filings, results, news

Financials

Reported figures only · latest: Q4 2025 USD · US GAAP
Net income −$10.5M +24.5% vs same quarter last year
EPS, diluted -
Operating cash flow −$9.3M +21% vs same quarter last year
Operating income −$9.3M +38.2% vs same quarter last year
Net income by quarter
−$17M
−$15.2M
−$17.1M
−$13.9M
−$15.4M
−$13.2M
−$11.1M
−$10.5M
Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
−$80M−$60M−$40M−$20M$0$20MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearNet income
FY25−$50.2M
FY24−$63.2M
FY23−$71.1M
FY22$5.2M
FY21−$35.2M
FY20−$12.9M
FY19-
Free cash flowOperating cash flow minus capital expenditure
−$80M−$60M−$40M−$20M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$45.2M
FY24−$50.1M
FY23−$64M
FY22−$66.6M
FY21−$34.6M
FY20−$12.2M
FY19-

News

No stories filed under Vicarious Surgical yet - coverage appears here as the news feed clusters it.